We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
DNApal is a personalised diet, health and fitness app that combines DNA infomation with other factors like age, weight, diet, family history and health goals. Two of the largest consumer DNA companies, 23andMe and Ancestry.com, have tested over 18m people. DNApal is capable of interpreting DNA results from these companies to provide precise recommendations on how to improve diet, hormone balance, weight loss, sleep, fitness & more. The company also won the best pitch at VentureFest 2019 at Oxford Brookes University. DNApal is aiming to launch MVP in January 2020 (iOS). The company is also aiming to recommend further testing and specific supplements where necessary and offer 1:1 consultations with a specialist. With the fund raised, DNApal plans to develop the full scope of the app, weekly goals, content challenges to keep users committed.

Pitch Rated

70%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £49,990
A grocery delivery service able to provide goods to your home almost 1 hour later from a selection of your favourite supermarkets. Home Run does not have any stock, stores or vans and instead uses personal shoppers to handpick a customer's supermarket run for them and deliver it via car or scooter.
days to go: Expired investment: £558,307
Fitch Brew Co has developed a new approach to coffee in the form of cold brew coffee. The brand has been designed to target the alcohol industry and work behind the bar with a flavour specifically developed to compliment alcoholic drinks. 
days to go: Expired investment: £148,280
Run An Empire is a mobile app that is encouraging people to get outside and start jogging/ running more often using gamification. The idea behind the app is that users run around a particular area and then that area is claimed as their 'territory' until another user jogs that area and then claims it. 
days to go: Expired investment: £60,370
Roqberry is a high-quality blended speciality tea made for millennial foodies. The company has received 20 Great Taste Awards and has secured listings with high-end distributors. It is stocked in speciality restaurants and retailers. Roqberry has been named as one of The Independent's "Best Plastic-Free Teabags". Already selling its products via its online shop and Amazon, the company is in discussion with other F&B chains, retailers and a major hotel. Roqberry is looking forward to scaling its B2B sales and B2C by hiring an account manager and new ops.

Pitch Rated

64%

Overall

rating powered by

CROWD RATING™

days to go: Expired investment: £152,290
With the rise of coffee and its many variations, it’s time for tea to take the spotlight. TeaTimed want to rediscover the lost art of creating a great cuppa by controlling the key-variables during the brewing process, to consistently produce a high-quality beverage. TeaTimed aim to re-invent tea from a just a 'service' for customers, to an unforgettable experience.
days to go: Expired investment: £18,290
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph